Web12 jul. 2016 · ABOUT IONIS PHARMACEUTICALS, INC. Ionis is the leading company in RNA-targeted drug discovery and development focused on developing drugs for patients … Web28 feb. 2024 · Press Releases. Year. Mar 27, 2024. Ionis reports positive topline 66-week results of eplontersen Phase 3 study for patients with ATTRv-PN. Mar 22, 2024. Ionis …
IONIS PHARMACEUTICALS, INC. : Unternehmensmitteilungen IONIS ...
WebGrâce à la diversité des écoles du Groupe IONIS, Ionis-STM a pu poser les bases de ces nouveaux cursus. Réorientez vos études vers un secteur en pleine évolution : les … Web4 nov. 2024 · Bayer is punting an Ionis Pharmaceuticals-partnered drug back to the biotech, giving up on a program on which it had spent more than $200 million. The … imhoff appliance
Ionis Pharmaceuticals - Our Investments - BB Biotech AG
WebIonis Pharmaceuticals, Inc. 29,782 followers on LinkedIn. For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing … Web10 apr. 2024 · Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. About the company Rewards Trading at 83.7% below our estimate of its fair value Revenue is forecast to grow 17.52% per year Risk Analysis Currently unprofitable and not forecast to become profitable over the next 3 years Web31 dec. 2024 · Ionis Pharmaceuticals Key Facts per 31.12.2024 Sitz USA Portfoliogewichtung 11.0% Anteil am Unternehmen 6.8% Marktkapitalisierung USD 5.4 Mrd. Sektor Genmedizin, Antisense-Technik Führender Produktkandidat Mehrere Hauptindikation Neurologische, kardiovaskuläre und respiratorische Erkrankungen list of primeval episodes wikipedia